Ledger.

University of Queensland

Dr Bruce Wyse

Coverage

Stories naming Dr Bruce Wyse. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

3 deals

Australian pain drug innovation company Spinifex Pharmaceuticals sold to Novartis for US$200m plus milestone payments

GBS Ventures reports Novartis has agreed to acquire chronic-pain drug developer Spinifex Pharmaceuticals for US$200 million upfront plus milestones, recalling the company's 2005, 2008 and 2014 venture rounds and its Australian investors.

GBS Ventures Tue 30 Jun 2015 Spinifex PharmaceuticalsBourns Semiconductor IncBrandon CapitalBT ImagingFibrotechFultecHatchtechHydrexiaMedical Research Commercialisation Fund (MRCF)NovartisNovo A/SQuest Software Inc.Shire plcSmart SparrowUniversity of QueenslandUNSW SydneyVintelaAustralianSuperCanaan PartnersGBS VenturesMTAA SuperNovo VenturesUniQuestUniseedUniversity of MelbourneDr Andrew BakerBrigitte SmithDr Bruce WyseDr Chris NaveProf Maree SmithMark AshtonDr Peter DevineDr Tom McCarthy

Also GBS Ventures·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·novartis.com·clinicalleader.com·Brandon Capital portfolio·Startup Daily·Startup Daily·Startup Daily·anthillonline.com·@AuManufacturing·materresearch.org.au·Business News Australia

Something wrong? Tell us